Best Biotech Stocks Worth Buying at the Moment 

Biotech stocks are not for everyone due to various reasons. Companies such as Moderna, and others have the potential to develop life-changing products that can lead to price upside for investors. Nonetheless, investors are always at the mercy of Food and Drug Administration approvals and headlines which can expose them to significant downside risk should these companies fail to deliver positive results. So, biotech is one of the most high-risk, high-rewards sectors of the stock market. 

Moderna is a great example of just how much upside these types of companies have. It is focused on creating transformative medicines based on messenger RNA (mRNA). Medicaments produced by Moderna have the potential to help with a huge spectrum of different diseases as well as illnesses. Massachusetts-based company is already generating billions with its COVID-19 vaccine. 

The company secured advance COVID-19 vaccine purchase agreements for about $20 billion for the year 2021, with orders confirmed for the next two years as well. 

Interesting biotech stocks 

Investors looking for the best biotech stocks should pay more attention to Illumina. It provides sequencing as well as array-based solutions for genetic analysis. Genomic research centers, hospitals, and others are buying its products. 

Illumina’s machines are also important for tracking and monitoring the spread of new variants of the COVID-19 virus. 

Regeneron Pharmaceuticals is also part of this list. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of various diseases. Investors might be familiar with Regeneron’s double-antibody cocktail therapy, REGN-COV. Doctors are using REGN-COV to treat mild to moderate coronavirus disease. This double-antibody cocktail therapy can potentially prevent severe symptoms. REGN-COV received emergency use authorization from the Food and Drug Administration. The company also has other successful drugs that round out a diverse portfolio.